Abstract

The effects of DNMT1 on human colorectal cancer cell proliferation and apoptosis as well as the possible underlying mechanisms were investigated. SW480 cells were treated with the DNA methyltransferase inhibitor 5-AZA-CdR. qRT-PCR was used to analyze mRNA expression, whereas protein expression was evaluated by western blotting. Cell growth, migration, and invasion were measured by MTT, transwell migration, and wound healing assays, respectively. Cell morphology was observed using hematoxylin and eosin (H&E) staining. 5-AZA-CdR treatment inhibited DNMT1 expression in colorectal cancer cells. Further, low expression of DNMT1 regulated RASSF1A-mediated inhibition of CyclinD1 expression, as well as colon cancer cell morphology, proliferation, and migration via RASSF1A methylation. Our results provide a basis for therapeutic strategies based on DNMT1 and RASSF1A for colorectal cancer.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.